• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Kamala Harris should prosecute Big Pharma, not bail it out

by October 7, 2024
written by October 7, 2024

With less than six weeks before the election, Vice President Kamala Harris has been striking a populist tone, especially when it comes to taking on Big Pharma in her stump speeches. At a recent campaign rally, she touted her tie-breaking vote to pass the Inflation Reduction Act, which granted Medicare the ability ‘to go toe-to-toe with Big Pharma and negotiate lower drug prices.’ 

And to great fanfare, just before the Democratic National Convention, the White House announced that the first round of those drug price negotiations would save taxpayers a cool $6 billion – a major win for the American taxpayer.  

Yet at this very moment, the Biden-Harris administration is quietly pushing for a multi-billion-dollar bailout of one of the nation’s largest and wealthiest drug companies – a bailout that would be funded by those same taxpayers.  

The proposed bailout revolves around a patent infringement lawsuit. Arbutus and Genevant Sciences, two small biotech companies, allege that Moderna stole their patented lipid nanoparticle technology, which proved critical in developing Moderna’s mRNA vaccine for COVID-19. 

Though the case is yet to be decided, the U.S. Patent and Trademark Office and Federal Circuit Court of Appeals have already determined Arbutus’ patents to be valid, despite Moderna’s attempt to invalidate the patents before the pandemic. Given the stakes of this case, court-ordered damages could reach $3 billion, according to some analysts. 

While this may appear to many as an obscure issue of corporations battling it out over patent infringement, there are serious ramifications for taxpayers here as well.  

In a rare statement of interest filing, Department of Justice officials recently argued that due to an obscure federal law dating back to World War I, Moderna is excused from any patent infringement that may have occurred during Operation Warp Speed, the historic federal campaign to support COVID-19 vaccine development. If that’s the case, the lion’s share of the financial penalty for Moderna’s potential wrongdoing will fall on U.S. taxpayers.  

The law, known as Section 1498, essentially states that the government will compensate an inventor for patent infringement if the technology in question is ‘used or manufactured by or for the United States.’  

In times of great national need, the government may decide they need niche technology at a scale that the original patent-holding manufacturer can’t provide. The law absolves the larger manufacturer from having to worry about licensing the patent from the original patent-holder or deal with the patent-holder taking them to court for infringement. 

Put more simply, Section 1498 is similar to eminent domain, but rather than letting the government seize private land, it allows the government to seize patented inventions in emergencies and retroactively compensate the patent holders. 

Here’s where the DOJ’s argument falls short, as Moderna’s infringement clearly should not be covered by Section 1498. The government never asked them to infringe on the intellectual property of anyone else and never authorized widespread production of Moderna’s COVID-19 vaccine by other companies due to manufacturing capacity issues.  

And critically, the vaccines in question weren’t used exclusively or even primarily by the U.S. government – meaning military service members or other federal employees – but were instead distributed to regular Americans like you and me.  

Yet at this very moment, the Biden-Harris administration is quietly pushing for a multi-billion-dollar bailout of one of the nation’s largest and wealthiest drug companies – a bailout that would be funded by those same taxpayers.  

‘By or for’ government use has always been understood to mean that the U.S. government is the end user of the product in question – for instance, a patented technology that’s appropriated for U.S. military use – not that it’s merely a purchaser. Objectively, the U.S. government was merely one buyer among many purchasers of the vaccines – including many foreign governments and other foreign state-owned companies.  

If the court overseeing the case accepts the DOJ’s interpretation of Section 1498, it will set a precedent that companies that merely sell to the government, among other customers, are immune from patent infringement lawsuits. That result would be disastrous for our economy and a boon to wrongdoers. 

Patents encourage innovation and risk-taking by enabling anyone with a novel idea to turn it into a real-world product – without bigger, entrenched rivals stealing it. Allowing huge corporations to essentially steal patented technology from small upstarts is the opposite of standing up for the little guy. It’d greatly disincentivize investments in research and development. 

Harris has a strong history of standing up for the ‘little guy’ going back to her early years as a prosecutor and San Francisco District attorney. The vice president should continue that legacy and make clear that in a Harris administration, large corporations will be held accountable if found responsible – a winning message in the final campaign stretch.  

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Saving lives on ‘Death Street,’ how an Israeli kindergarten teacher became a battlefield hero on October 7
next post
Women for Trump, Goya team up to provide relief to Hurricane Helene victims in Georgia

related articles

Hawley blasts FDA approval of new abortion drug,...

October 2, 2025

Trump’s DOGE savings dwarfed by Medicare, Social Security...

October 2, 2025

FLASHBACK: James Comey urged officials to always prosecute...

October 2, 2025

The agency staff Vought might recommend cutting and...

October 2, 2025

Reagan-appointed judge, once rebuked by Supreme Court, continues...

October 2, 2025

‘Real consequences’: Food aid, flood insurance, FEMA funds...

October 2, 2025

Trump must triple severely outdated nuke arsenal to...

October 2, 2025

White House says federal layoffs could hit ‘thousands’...

October 2, 2025

Johnson shuts door on negotiating shutdown deal as...

October 2, 2025

Democrats refuse to budge over Obamacare fight as...

October 2, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Google makes first foray into fusion in venture with MIT spinoff Commonwealth Fusion Systems

    July 1, 2025
  • Here’s what happened during President Donald Trump’s eighth week in office

    March 15, 2025
  • House Republicans lament Trump’s ‘terrible’ debate performance: ‘Let her get under his skin’

    September 12, 2024
  • CHARLIE KIRK: Republicans must seize Gen Z moment or risk losing an entire generation

    July 26, 2025
  • Hegseth says Defense Dept eliminates hundreds of millions in ‘wasteful’ spending after DOGE findings

    March 21, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,247)
  • Investing (634)
  • Stock (935)

Latest Posts

  • Harris preps for debate with Google lawyer, creating ‘conflict of interest,’ Trump campaign says

    August 26, 2024
  • Trump says US will deal ‘directly’ with Iran in high-level meeting on Saturday

    April 7, 2025
  • Trump calls Springsteen ‘highly overrated’ after rocker labels him ‘treasonous’ overseas

    May 16, 2025

Recent Posts

  • Trump selects South Dakota Governor Kristi Noem to run Department of Homeland Security

    November 13, 2024
  • AOC launches series of explosive Instagram rants on eve of inauguration: ‘I don’t celebrate rapists’

    January 20, 2025
  • National Guard report refutes Tim Walz’s claim of actually toting war weapons ‘in war’

    August 8, 2024

Editor’s Pick

  • ‘RFK’ing the french fries’: Steak ‘n Shake becomes a MAHA darling

    March 17, 2025
  • Biden announcement makes him first US president to not seek re-election since 1968

    July 21, 2024
  • ‘Nail in the coffin’: Grocer turned House lawmaker trashes Kamala Harris’ price control plan

    August 24, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock